Clinka Dosage

• Dosage of Clinka in details
• Clinka interactions
• Clinka reviews

Dosage of Clinka in details

Apply a thin film of Clinka

Topical Solution, Clinka

Topical Lotion, Clinka

Topical Gel, or use a Clinka

Topical Solution pledget for the application of Clinka twice daily to affected area. More than one pledget may be used. Each pledget should be used only once and then be discarded.

Lotion: Shake well immediately before using.

Pledget: Remove pledget from foil just before use. Do not use if the seal is broken. Discard after single use.

Keep all liquid dosage forms in containers tightly closed.

How supplied

Clinka

Topical Solution

containing clindamycin phosphate equivalent to 10 mg clindamycin per milliliter is available in the following sizes:

30 mL applicator bottle - NDC 0009-3116-01

60 mL applicator bottle - NDC 0009-3116-02

Carton of 60 single-use pledget applicators - NDC 0009-3116-14

Clinka

Topical Gel

containing clindamycin phosphate equivalent to 10 mg clindamycin per gram is available in the following sizes:

60 gram tube - NDC 0009-3331-01

30 gram tube - NDC 0009-3331-02

Clinka

Topical Lotion

containing clindamycin phosphate equivalent to 10 mg clindamycin per milliliter is available in the following size:

60 mL plastic squeeze bottle - NDC 0009-3329-01

Store at controlled room temperature 20° to 25°C (68° to 77°F).

Protect from freezing.

Distributed by: Pharmacia & Upjohn Company, Division of Pfizer Inc., NY, NY 10017. Revised April 2014

What other drugs will affect Clinka?

Before using Clinka, tell your doctor if you are using any of the following drugs:

• erythromycin topical (Akne-Mycin, Emcin Clear, Eryderm, Erygel, Erythra-Derm, Ery-Sol, and others); or
• erythromycin taken by mouth (E.E.S., E-Mycin, Ery-Tab, E-Mycin, Robimycin, and others).

This list is not complete and other drugs may interact with Clinka. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

Clinka interactions

Clinka has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore, it should be used with caution in patients receiving such agents. Antagonism has been demonstrated between clindamycin and erythromycin in vitro. Because of possible clinical significance, these two drugs should not be administered concurrently.

References

1. FDA/SPL Indexing Data. "3U02EL437C: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
2. MeSH. "Protein Synthesis Inhibitors". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
3. European Chemicals Agency - ECHA. "Clindamycin: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Clinka are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Clinka. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 19 here

Information checked by Dr. Sachin Kumar, MD Pharmacology